Skip To Main Content
OTC Drugs on Muck Rack

OTC Drugs

As seen in: Digital Journal, EIN News, MENAFN, openPR, EIN Presswire, The Daily Times (Maryville, TN), Prsync.com, Ellensburg Daily Record, WhaTech, Article Scad and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with OTC

Contact OTC, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Consumer Healthcare Market Research Report: Revenue, Market Share & Future Scope

|
By OTC Drugs
| Article Scad
Consumer Healthcare Market Research Report: Revenue, Market Share & Future Scope Author : Prashant Manjarekar | Published On : 13 Mar 2026 Consumer Healthcare MarketReport The market research report on the Consumer Healthcare Market industry provides crucial insights into current growth trends and primary revenue drivers from 2025 to 2034. It explores various elements impacting the Consumer Healthcare Market, offering a thorough understanding of its dynamics.
Open in Who Shared View Duplicates (3) Issue with article?

Antiobesity Global Market Report 2026

|
By OTC Drugs
| Global information inc
Anti-obesity drugs are medications used to reduce or manage a patient's weight. These drugs work by targeting one of the body's fundamental functions-weight control-either by influencing appetite or affecting calorie absorption. Maintaining a healthy diet and engaging in regular exercise remain the primary therapeutic strategies for individuals who are overweight or obese. The primary categories of drugs used in anti-obesity treatment are those that act peripherally and those that act centrally.
Open in Who Shared View Duplicates (74) Issue with article?

Last Friday was a Good Day for Those Who Want to Litigate Against the Federal Government.

|
By JP Ellison, OTC Drugs
| thefdalawblog.com
Last Friday, the Supreme Court delivered a trio of decisions making it easier to litigate against the federal government. The facts and law in each case matter, and as is often the case when the Supreme Court “decides” an issue, much remains to be seen. That said, it’s hard to see how the score on Friday wasn’t 3 for regulated industry and 0 for the federal government. In a pair of 7-2 decisions authored by Justice Kavanaugh, the Court took the more expansive view of who can sue the government.
Open in Who Shared Issue with article?
See all 22 articles